4//SEC Filing
McGovern Jr. Donald A. 4
Accession 0001213900-22-028975
CIK 0001690080other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:31 PM ET
Size
10.3 KB
Accession
0001213900-22-028975
Insider Transaction Report
Form 4
McGovern Jr. Donald A.
Director
Transactions
- Award
Common Stock
2022-05-19$1.36/sh+12,409$16,876→ 50,587 total - Award
Non-Qualified Stock Option (right to buy)
2022-05-19+15,000→ 15,000 totalExercise: $1.36Exp: 2032-05-19→ Common Stock (15,000 underlying) - Award
Non-Qualified Stock Option (right to buy)
2022-05-19+134,121→ 134,121 totalExercise: $1.36From: 2022-05-19Exp: 2032-05-19→ Common Stock (134,121 underlying)
Footnotes (4)
- [F1]Issued in consideration for serving on the Board of Directors, as Lead Director, Chairman of the Audit Committee, and as a Member of the Compensation Committee and of the Risk, Safety and Regulatory Committee of the Board of Directors, for the quarter ended March 31, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F2]Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F3]The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the following 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company.
- [F4]Granted in consideration for serving as Lead Director of the Company during 2021 and 2022 (to date). Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001706276
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:31 PM ET
- Size
- 10.3 KB